share_log

Lineage Cell Therapeutics Shares Up 5%; Hearing Baird Initiates With $5 Price Target

Benzinga Real-time News ·  Nov 2, 2022 05:24
Lineage Cell Therapeutics Shares Up 5%; Hearing Baird Initiates With $5 Price Target
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment